Provider review
CoreAge Rx review
One flat price, and the low dose is the product rather than a shortfall.
Two named low-dose programmes with their own prices, so starting small is not a discount on a full-dose plan.
Price as published
Semaglutide Microdose $79/mo · Tirzepatide Microdose $129/mo (flat)
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The verdict
CoreAge Rx is the only provider on this board whose low-dose programmes are priced as products in their own right rather than as the bottom rung of a weight-loss ladder — a semaglutide microdose and a tirzepatide microdose, each with its own flat monthly rate and no membership or lab fee underneath it. A named 503A pharmacy fills it and nurse and registered-dietitian consults are included rather than sold as an upgrade, which is unusual at this price. It is also the site's paid partner, and it is ranked first; both of those are true at once and neither is hidden.
The trade-off we would want you to read first
Focused on low-dose metabolic protocols — not a full-titration weight-loss clinic
Who it suits, and who it does not
A good fit if
- You want a stated low-dose protocol rather than to self-direct a small dose inside a standard plan
- You want the medication, the clinician and the support in one price, with nothing billed alongside it
- You want to know which kind of pharmacy is filling the vial before you order
Look elsewhere if
- You expect to titrate up to a full weight-loss dose — this is not a full-titration clinic
- You want brand-name Wegovy, Zepbound or Ozempic rather than a compounded product
- You are needle-averse and want drops, a lozenge or a tablet instead of an injection
How the programme works
U.S.-licensed clinicians review an online intake, then a low-dose GLP-1 protocol is filled by a 503A compounding pharmacy. CoreAge runs two longevity-oriented programs: a Semaglutide Microdose (up to 0.125 mg, $79/mo) and a Tirzepatide Microdose (dual GIP/GLP-1, up to 1.25 mg, $129/mo), framed for metabolic baseline and appetite — not aggressive weight loss. Every plan includes 1:1 nurse and registered-dietitian consults, an automatic refund if you are not approved, and roughly 2-business-day shipping. Monthly recurring, with no separate membership or lab fee.
At a glance
- Pricing structure
- Flat at every dose
- Consult
- Included in the price
- Compounding
- 503A
- Labs
- Not required
- Dietitian support
- Included
Strengths
- Transparent flat pricing — $79/mo semaglutide, $129/mo tirzepatide, with no membership or lab surcharge
- Doctor-reviewed protocols filled by a 503A compounding pharmacy
- Included 1:1 support from nurses and registered dietitians
- Automatic refund if you are not approved for treatment
- Explicit low-dose, longevity-and-metabolic framing rather than max-dose weight-loss marketing
The other trade-offs
- Like all compounded GLP-1s, the product is not FDA-approved, and intentional microdosing is off-label and unproven (see our evidence review)
Before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Where this sits on the board
CoreAge Rx is one of 24 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Funding & disclosures
- A number of links are affiliate or referral links.
- Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
- What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
- Full detail: disclosure page.